Testing effectiveness (Phase 2)Study completedNCT01217060What this trial is testingTrimodality Management of T1b Esophageal CancersWho this might be right forEsophageal Cancer M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT03365791What this trial is testingPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesWho this might be right forSmall Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more Novartis Pharmaceuticals 76
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT02389751What this trial is testingGanetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerWho this might be right forGastroesophageal Junction AdenocarcinomaMalignant Neoplasm of the Cervical EsophagusMalignant Neoplasm of the Thoracic Esophagus+5 more M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00047112What this trial is testingSurgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal CancerWho this might be right forEsophageal Cancer Federation Francophone de Cancerologie Digestive 195
Not applicableStudy completedNCT03301493What this trial is testingGenomic Testing and Resulting Medical DecisionsWho this might be right forCancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Early research (Phase 1)Study completedNCT06549816What this trial is testingSGN-B6A in Chinese Participants With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 6
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Looking for participantsNCT07277413What this trial is testingIDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsWho this might be right forNSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+8 more IDEAYA Biosciences 260
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Early research (Phase 1)Looking for participantsNCT07284186What this trial is testingFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsWho this might be right forEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more Plexium, Inc. 155
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Early research (Phase 1)Looking for participantsNCT07090499What this trial is testingLearn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsWho this might be right forAdvanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more Pfizer 310
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated with Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00252889What this trial is testingDoxil Topotecan Doublet Cancer StudyWho this might be right forSmall Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more Christiana Care Health Services 20
Early research (Phase 1)Looking for participantsNCT04615013What this trial is testingNBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerWho this might be right forCervical Esophagus AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8+10 more M.D. Anderson Cancer Center 24
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more Adaptimmune 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184